Cargando…
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
COVID-19 is one of the most impactful pandemics in recorded history. As such, the identification of inhibitory drugs against its etiological agent, SARS-CoV-2, is of utmost importance, and in particular, repurposing may provide the fastest route to curb the disease. As the first step in this route,...
Autores principales: | Singh Tomar, Prabhat Pratap, Arkin, Isaiah T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305885/ https://www.ncbi.nlm.nih.gov/pubmed/32828269 http://dx.doi.org/10.1016/j.bbrc.2020.05.206 |
Ejemplares similares
-
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021) -
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021) -
Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
por: Singh, Anamika, et al.
Publicado: (2022) -
Zika M—A Potential Viroporin: Mutational Study and Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2022) -
Potential Viroporin Candidates From Pathogenic Viruses Using Bacteria-Based Bioassays
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2019)